Health care partner Tom Bulleit (Washington, D.C.) is quoted in a Bloomberg Law article on March 11 that examines the impact of pay-for-delay prescription drug deals.
Mr. Bulleit suggests that the proposed CREATES Act, which would give generic drugmakers modest additional tools to more quickly bring a generic to market, may be more likely to succeed than other more forceful measures that have been discussed in Congress and in President Trump’s budget.
Attorneys
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.